Publications

Cancer treatment reviews

Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments.

01-11-2022

Biomedical chromatography : BMC

Bioanalytical assay for the quantification of the tyrosine kinase inhibitor EAI045 and its major metabolite PIA in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry.

01-11-2022

Annals of oncology : official journal of the European Society for Medical Oncology

ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe.

01-11-2022

The Journal of urology

Financial Toxicity After Robot-Assisted Radical Prostatectomy and Its Relation with Oncologic, Functional Outcomes.

01-11-2022

British journal of cancer

Somatic hits in mismatch repair genes in colorectal cancer among non-seminoma testicular cancer survivors.

01-11-2022

Journal of clinical and experimental neuropsychology

Standardized item selection for alternate computerized versions of Rey Auditory Verbal Learning Test(-based) word lists.

01-11-2022

Journal of geriatric oncology

Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥ 70 years with ultralow risk of distant recurrence: A population-based cohort study.

01-11-2022

European journal of cancer care

Feasibility of a supervised and home-based tailored exercise intervention in head and neck cancer patients during chemoradiotherapy.

01-11-2022

European journal of cancer (Oxford, England : 1990)

Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study.

01-11-2022

Epidemiology (Cambridge, Mass.)

The Authors Respond.

01-11-2022

Cancer chemotherapy and pharmacology

Idiopathic hyperammonemic encephalopathy secondary to gemcitabine-cisplatin treatment.

01-11-2022

European journal of cancer (Oxford, England : 1990)

Ten-year follow-up of the observational RASTER study, prospective evaluation of the 70-gene signature in ER-positive, HER2-negative, node-negative, early breast cancer.

01-11-2022

Trends in genetics : TIG

Slippy-Sloppy translation: a tale of programmed and induced-ribosomal frameshifting.

01-11-2022

Gynecologic oncology

Peroperative extent of peritoneal metastases affects the surgical outcome and survival in advanced ovarian cancer.

01-11-2022

Clinical pharmacokinetics

Semi-mechanistic Modeling of Hypoxanthine, Xanthine, and Uric Acid Metabolism in Asphyxiated Neonates.

01-11-2022

Annals of oncology : official journal of the European Society for Medical Oncology

Validation of cancer-type-dependent benefit from immune checkpoint blockade in TMB-H tumors identified by the FoundationOne CDx assay.

01-11-2022

European journal of cancer (Oxford, England : 1990)

Imaging standardisation in metastatic colorectal cancer: A joint EORTC-ESOI-ESGAR expert consensus recommendation.

01-11-2022

Lung cancer (Amsterdam, Netherlands)

Development of an updated, standardized, patient-centered outcome set for lung cancer.

01-11-2022

Preventive medicine

Guidance for setting international standards on reporting longitudinal adherence to stool-based colorectal cancer screening.

01-11-2022

Nature medicine

Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome.

01-11-2022

The Journal of pathology

R-spondin-3 is an oncogenic driver of poorly differentiated invasive breast cancer.

01-11-2022

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Integrated MRI-linac systems: The new paradigm for precision adaptive radiotherapy and biological image-guidance?

01-11-2022

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Robot-Assisted Prostate-Specific Membrane Antigen-Radioguided Surgery in Primary Diagnosed Prostate Cancer.

01-11-2022

European journal of cancer (Oxford, England : 1990)

Real-world outcomes with ipilimumab and nivolumab in advanced melanoma: a multicentre retrospective study.

01-11-2022

NEJM evidence

Five-Year Analysis of Adjuvant Pembrolizumab or Placebo in Stage III Melanoma.

01-11-2022

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Mindfulness is associated with severity of peripheral neuropathy and related patient-reported outcomes among colorectal cancer patients.

01-11-2022

Seminars in cancer biology

Therapy-induced shaping of the glioblastoma microenvironment: Macrophages at play.

01-11-2022

Nature communications

A doxycycline- and light-inducible Cre recombinase mouse model for optogenetic genome editing.

28-10-2022

Cancer research communications

Loss of the volume-regulated anion channel components LRRC8A and LRRC8D limits platinum drug efficacy.

26-10-2022

Cancers

A Negative Body Image among Adolescent and Young Adult (AYA) Cancer Survivors: Results from the Population-Based SURVAYA Study.

26-10-2022

Developmental cell

MYO10-filopodia support basement membranes at pre-invasive tumor boundaries.

24-10-2022

Breast cancer research : BCR

PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients.

21-10-2022

Molecular cell

Alternative cleavage and polyadenylation generates downstream uncapped RNA isoforms with translation potential.

20-10-2022

Insights into imaging

Retrospective evaluation of national MRI reporting quality for lateral lymph nodes in rectal cancer patients and concordance with prospective re-evaluation following additional training.

20-10-2022

Molecular cell

DNA-PKcs promotes fork reversal and chemoresistance.

20-10-2022

Cancer research

Boosting Antitumor Immunity with an Expanded Neoepitope Landscape.

17-10-2022

eLife

Quantifying how post-transcriptional noise and gene copy number variation bias transcriptional parameter inference from mRNA distributions.

17-10-2022

International journal of cancer

Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial.

15-10-2022

Med (New York, N.Y.)

Next generation T cell therapies for solid cancers.

14-10-2022

Clinical cancer research : an official journal of the American Association for Cancer Research

Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy-Resistant Early Breast Cancers.

14-10-2022

Endocrinology

Homing in on a Moving Target: Androgen Receptor Cistromic Plasticity in Prostate Cancer.

11-10-2022

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Minus Times Minus Equals Plus.

10-10-2022

Cancer discovery

Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer.

05-10-2022

BMC medical informatics and decision making

Need for numbers: assessing cancer survivors' needs for personalized and generic statistical information.

05-10-2022

Cancer discovery

When Cancer Cells Become the Enablers of an Antitumor Immune Response.

05-10-2022

Frontiers in oncology

Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose?

04-10-2022

Breast (Edinburgh, Scotland)

Efficacy of neoadjuvant treatment with or without pertuzumab in patients with stage II and III HER2-positive breast cancer: a nationwide cohort analysis of pathologic response and 5-year survival.

01-10-2022

Physics and imaging in radiation oncology

Benchmarking daily adaptation using fully automated radiotherapy treatment plan optimization for rectal cancer.

01-10-2022

Clinical radiology

Axillary lymph node response to neoadjuvant systemic therapy with dedicated axillary hybrid ¹⁸F-FDG PET/MRI in clinically node-positive breast cancer patients: a pilot study.

01-10-2022

Pharmaceutical research

Exposure-Response Analysis of Osimertinib in EGFR Mutation Positive Non-Small Cell Lung Cancer Patients in a Real-Life Setting.

01-10-2022

Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments.

Bioanalytical assay for the quantification of the tyrosine kinase inhibitor EAI045 and its major metabolite PIA in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry.

ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe.

Financial Toxicity After Robot-Assisted Radical Prostatectomy and Its Relation with Oncologic, Functional Outcomes.

Somatic hits in mismatch repair genes in colorectal cancer among non-seminoma testicular cancer survivors.

Standardized item selection for alternate computerized versions of Rey Auditory Verbal Learning Test(-based) word lists.

Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥ 70 years with ultralow risk of distant recurrence: A population-based cohort study.

Feasibility of a supervised and home-based tailored exercise intervention in head and neck cancer patients during chemoradiotherapy.

Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study.

The Authors Respond.

Idiopathic hyperammonemic encephalopathy secondary to gemcitabine-cisplatin treatment.

Ten-year follow-up of the observational RASTER study, prospective evaluation of the 70-gene signature in ER-positive, HER2-negative, node-negative, early breast cancer.

Slippy-Sloppy translation: a tale of programmed and induced-ribosomal frameshifting.

Peroperative extent of peritoneal metastases affects the surgical outcome and survival in advanced ovarian cancer.

Semi-mechanistic Modeling of Hypoxanthine, Xanthine, and Uric Acid Metabolism in Asphyxiated Neonates.

Validation of cancer-type-dependent benefit from immune checkpoint blockade in TMB-H tumors identified by the FoundationOne CDx assay.

Imaging standardisation in metastatic colorectal cancer: A joint EORTC-ESOI-ESGAR expert consensus recommendation.

Development of an updated, standardized, patient-centered outcome set for lung cancer.

Guidance for setting international standards on reporting longitudinal adherence to stool-based colorectal cancer screening.

Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome.

R-spondin-3 is an oncogenic driver of poorly differentiated invasive breast cancer.

Integrated MRI-linac systems: The new paradigm for precision adaptive radiotherapy and biological image-guidance?

Robot-Assisted Prostate-Specific Membrane Antigen-Radioguided Surgery in Primary Diagnosed Prostate Cancer.

Real-world outcomes with ipilimumab and nivolumab in advanced melanoma: a multicentre retrospective study.

Five-Year Analysis of Adjuvant Pembrolizumab or Placebo in Stage III Melanoma.

Mindfulness is associated with severity of peripheral neuropathy and related patient-reported outcomes among colorectal cancer patients.

Therapy-induced shaping of the glioblastoma microenvironment: Macrophages at play.

A doxycycline- and light-inducible Cre recombinase mouse model for optogenetic genome editing.

Loss of the volume-regulated anion channel components LRRC8A and LRRC8D limits platinum drug efficacy.

A Negative Body Image among Adolescent and Young Adult (AYA) Cancer Survivors: Results from the Population-Based SURVAYA Study.

MYO10-filopodia support basement membranes at pre-invasive tumor boundaries.

PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients.

Alternative cleavage and polyadenylation generates downstream uncapped RNA isoforms with translation potential.

Retrospective evaluation of national MRI reporting quality for lateral lymph nodes in rectal cancer patients and concordance with prospective re-evaluation following additional training.

DNA-PKcs promotes fork reversal and chemoresistance.

Boosting Antitumor Immunity with an Expanded Neoepitope Landscape.

Quantifying how post-transcriptional noise and gene copy number variation bias transcriptional parameter inference from mRNA distributions.

Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial.

Next generation T cell therapies for solid cancers.

Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy-Resistant Early Breast Cancers.

Homing in on a Moving Target: Androgen Receptor Cistromic Plasticity in Prostate Cancer.

Minus Times Minus Equals Plus.

Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer.

Need for numbers: assessing cancer survivors' needs for personalized and generic statistical information.

When Cancer Cells Become the Enablers of an Antitumor Immune Response.

Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose?

Efficacy of neoadjuvant treatment with or without pertuzumab in patients with stage II and III HER2-positive breast cancer: a nationwide cohort analysis of pathologic response and 5-year survival.

Benchmarking daily adaptation using fully automated radiotherapy treatment plan optimization for rectal cancer.

Axillary lymph node response to neoadjuvant systemic therapy with dedicated axillary hybrid 18F-FDG PET/MRI in clinically node-positive breast cancer patients: a pilot study.

Exposure-Response Analysis of Osimertinib in EGFR Mutation Positive Non-Small Cell Lung Cancer Patients in a Real-Life Setting.

This site uses cookies

Axillary lymph node response to neoadjuvant systemic therapy with dedicated axillary hybrid ¹⁸F-FDG PET/MRI in clinically node-positive breast cancer patients: a pilot study.